Translocase of Inner Membrane 50 Functions as a Novel Protective Regulator of Pathological Cardiac Hypertrophy [Heart Failure]

ConclusionsThese data indicated that TIM50 could attenuate pathological cardiac hypertrophy primarily by reducing oxidative stress. TIM50 could be a promising target for the prevention and therapy of cardiac hypertrophy and heart failure.

Source: JAHA:Journal of the American Heart Association - April 21, 2017 Category: Cardiology Authors: Tang, K., Zhao, Y., Li, H., Zhu, M., Li, W., Liu, W., Zhu, G., Xu, D., Peng, W., Xu, Y.-w. Tags: Basic Science Research, Hypertrophy Original Research Source Type: research